Maria E Aguero-Rosenfeld

Summary

Affiliation: New York Medical College
Country: USA

Publications

  1. ncbi Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York
    Maria E Aguero-Rosenfeld
    Division of Infectious Diseases, Department of Medicine, New York Medical College and Westchester Medical Center, Valhalla, New York 10595, USA
    J Clin Microbiol 40:2612-5. 2002
  2. ncbi Laboratory aspects of tick-borne diseases: lyme, human granulocytic ehrlichiosis and babesiosis
    Marie E Aguero-Rosenfeld
    Clinical Laboratories, Room 1J 11a, Westchester Medical Center, Valhalla, NY 10595, USA
    Mt Sinai J Med 70:197-206. 2003
  3. ncbi Diagnosis of human granulocytic ehrlichiosis: state of the art
    Maria E Aguero-Rosenfeld
    Department of Pathology, New York Medical College, Westchester Medical Center, Valhalla, New York 10595, USA
    Vector Borne Zoonotic Dis 2:233-9. 2002
  4. ncbi Diagnosis of lyme borreliosis
    Maria E Aguero-Rosenfeld
    Department of Pathology, Division of Infectious Diseases, New York Medical College, Valhalla, NY, USA
    Clin Microbiol Rev 18:484-509. 2005
  5. ncbi Lyme disease: laboratory issues
    Maria E Aguero-Rosenfeld
    Department of Pathology, Medicine, and Microbiology, New York Medical College, Valhalla, NY 10595, USA
    Infect Dis Clin North Am 22:301-13, vii. 2008
  6. ncbi Differences and similarities between culture-confirmed human granulocytic anaplasmosis and early lyme disease
    Gary P Wormser
    Department of Medicine, Division of Infectious Diseases, New York Medical College, Valhalla, New York, USA
    J Clin Microbiol 51:954-8. 2013
  7. ncbi Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease
    Gary P Wormser
    Division of Infectious Diseases, New York Medical College, Valhalla, NY 10595, USA
    Diagn Microbiol Infect Dis 75:9-15. 2013
  8. ncbi Dissociation between inhibition and killing by levofloxacin in human granulocytic anaplasmosis
    Gary P Wormser
    Division of Infectious Diseases, Depatment of Medicine, New York Medical College, Westcheser Medical Center, Valhalla, New York, USA
    Vector Borne Zoonotic Dis 6:388-94. 2006
  9. ncbi 2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test
    John A Branda
    Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    Clin Infect Dis 50:20-6. 2010
  10. ncbi Borrelia burgdorferi BmpA, BmpB, and BmpD proteins are expressed in human infection and contribute to P39 immunoblot reactivity in patients with Lyme disease
    Anton V Bryksin
    Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA
    Clin Diagn Lab Immunol 12:935-40. 2005

Detail Information

Publications14

  1. ncbi Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York
    Maria E Aguero-Rosenfeld
    Division of Infectious Diseases, Department of Medicine, New York Medical College and Westchester Medical Center, Valhalla, New York 10595, USA
    J Clin Microbiol 40:2612-5. 2002
    ..phagocytophila antibodies when the conventional cutoff titer of 80 is used in the IFA. This information must be considered in interpretation of test results...
  2. ncbi Laboratory aspects of tick-borne diseases: lyme, human granulocytic ehrlichiosis and babesiosis
    Marie E Aguero-Rosenfeld
    Clinical Laboratories, Room 1J 11a, Westchester Medical Center, Valhalla, NY 10595, USA
    Mt Sinai J Med 70:197-206. 2003
    ..Co-infections with these agents exist, but they should be documented by detection of the organisms rather than by serology, since seroprevalence rates are high in endemic areas...
  3. ncbi Diagnosis of human granulocytic ehrlichiosis: state of the art
    Maria E Aguero-Rosenfeld
    Department of Pathology, New York Medical College, Westchester Medical Center, Valhalla, New York 10595, USA
    Vector Borne Zoonotic Dis 2:233-9. 2002
    ..Serology has an important role in the confirmation of the diagnosis when used in paired specimens and when high cutoff titers by indirect fluorescence antibody assay (> or = 640) are used to diagnose a recent infection...
  4. ncbi Diagnosis of lyme borreliosis
    Maria E Aguero-Rosenfeld
    Department of Pathology, Division of Infectious Diseases, New York Medical College, Valhalla, NY, USA
    Clin Microbiol Rev 18:484-509. 2005
    ..Evaluation of these assays is currently being done, and there is evidence that certain of these antigens may be broadly cross-reactive with the B. burgdorferi sensu lato species causing LB in Europe...
  5. ncbi Lyme disease: laboratory issues
    Maria E Aguero-Rosenfeld
    Department of Pathology, Medicine, and Microbiology, New York Medical College, Valhalla, NY 10595, USA
    Infect Dis Clin North Am 22:301-13, vii. 2008
    ..Use and limitations of these methods are discussed. Current guidelines for the use of recommended serologic methods and discussion of newer methods also are provided...
  6. ncbi Differences and similarities between culture-confirmed human granulocytic anaplasmosis and early lyme disease
    Gary P Wormser
    Department of Medicine, Division of Infectious Diseases, New York Medical College, Valhalla, New York, USA
    J Clin Microbiol 51:954-8. 2013
    ..389, P = 0.009) was observed for HGA patients but not for patients with Lyme disease. In conclusion, although there are overlapping features, culture-confirmed HGA is a more severe illness than early Lyme disease...
  7. ncbi Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease
    Gary P Wormser
    Division of Infectious Diseases, New York Medical College, Valhalla, NY 10595, USA
    Diagn Microbiol Infect Dis 75:9-15. 2013
    ..The C6 ELISA had slightly decreased specificity. Future studies should evaluate the performance of the C6 ELISA compared with 2-tier testing in routine clinical practice...
  8. ncbi Dissociation between inhibition and killing by levofloxacin in human granulocytic anaplasmosis
    Gary P Wormser
    Division of Infectious Diseases, Depatment of Medicine, New York Medical College, Westcheser Medical Center, Valhalla, New York, USA
    Vector Borne Zoonotic Dis 6:388-94. 2006
    ..Relapse of infection after levofloxacin therapy was reproduced in a severe combined immune-deficient (SCID) mouse infection model. Quinolone therapy should not be considered curative of HGA...
  9. ncbi 2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test
    John A Branda
    Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    Clin Infect Dis 50:20-6. 2010
    ..IgG VlsE antibody testing, by itself, improves early sensitivity, but may lower specificity. We studied whether elements of the 2 approaches could be combined to produce a second-tier IgG blot that performs well throughout the infection...
  10. ncbi Borrelia burgdorferi BmpA, BmpB, and BmpD proteins are expressed in human infection and contribute to P39 immunoblot reactivity in patients with Lyme disease
    Anton V Bryksin
    Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA
    Clin Diagn Lab Immunol 12:935-40. 2005
    ..This suggests that at least three of the four Bmp proteins are expressed by B. burgdorferi in infected patients and that specific antibodies to them are likely to be present in the P39 band in some patients...
  11. ncbi Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease
    Gary P Wormser
    Department of Medicine, Division of Infectious Diseases, Munger Pavilion Room 245, New York Medical College, Valhalla, NY 10595, USA
    Clin Vaccine Immunol 15:1519-22. 2008
    ..Thus, in patients with erythema migrans, certain clinical variables such as the duration and number of skin lesions had a profound impact on seropositivity rates, irrespective of the serologic assay performed...
  12. ncbi Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity
    Harold W Horowitz
    Division of Infectious Diseases, Department of Medicine, New York Medical College, Munger Pavilion, Rm 245, Valhalla, NY 10595, USA
    Clin Infect Dis 56:93-9. 2013
    ..Conflicting data exist on the frequency of coinfection and on whether Lyme-HGA coinfected patients have more symptoms than patients with Lyme disease alone...
  13. ncbi Vertical transmission of Babesia microti, United States
    Julie T Joseph
    New York Medical College, Valhalla, New York 10595, USA
    Emerg Infect Dis 18:1318-21. 2012
    ..We report a case of babesiosis in an infant for whom vertical transmission was suggested by evidence of Babesia spp. antibodies in the heel-stick blood sample and confirmed by detection of Babesia spp. DNA in placenta tissue...
  14. ncbi Polyphyletic emergence of linezolid-resistant staphylococci in the United States
    Agnes Wong
    Department of Microbiology and Immunology, New York Medical College, Valhalla, NY, USA
    Antimicrob Agents Chemother 54:742-8. 2010
    ..epidermidis isolates. These findings suggest that linezolid resistance has emerged independently in multiple clones of S. aureus and with a variety of ribosomal mutations in multiple clones of S. epidermidis...